Cafepharma Today

October 4 2024 - Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply
Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply
Teva and mAbxience partner to develop biosimilar candidate for oncology
Thermo Fisher's plant making infant RSV drug breached FDA rules
Sanofi offloads rare autoimmune drug to Recordati in potential $1B deal
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

[podcast]Breaking down BIOSECURE—Industry implications and what comes next
Fierce Pharma
Friday, October 4, 2024 - 11:02am
tags:
Biosecure Act, legislation
Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reports
Reuters
Friday, October 4, 2024 - 9:41am
tags:
GSK, Sanofi, CSL, vaccines, bird flu
Ultragenyx tweaks gene therapy dosing to dial up efficacy after seeing signs of activity
Fierce Biotech
Friday, October 4, 2024 - 9:38am
tags:
Ultragenyx Pharmaceutical, Wilson disease, gene therapy, UX701
Teva and mAbxience partner to develop biosimilar candidate for oncology
Pharmaceutical Technology
Friday, October 4, 2024 - 9:28am
tags:
Teva Pharmaceutical, mAbxience, oncology, biosimilars
FDA grants priority review for AstraZeneca’s Calquence sNDA
Pharmaceutical Business Review
Friday, October 4, 2024 - 9:26am
tags:
AstraZeneca, Calquence, FDA, priority review
BD Moves to Settle the Majority of Its Hernia Mesh Litigation
Medical Devices and Diagnostics Industry
Friday, October 4, 2024 - 9:25am
tags:
Becton Dickinson, legal, hernia mesh, Medtech
Editas cashes in on portion of Vertex gene editing licensing agreement for $57M
Fierce Biotech
Friday, October 4, 2024 - 9:24am
tags:
Editas Medicine, Cas9, patents, Vertex Pharmaceuticals, gene editing
Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show
Reuters
Friday, October 4, 2024 - 9:22am
tags:
Thermo Fisher, FDA, RSV, Beyfortus, Sanofi, AstraZeneca, drug manufacturing
An Alzheimer’s drugmaker is accused of data ‘manipulation.’ Should its trials be stopped?
Pharma Voice
Friday, October 4, 2024 - 9:19am
tags:
Cassava Sciences, Alzheimer's disease, data manipulation
Boehringer Ingelheim and Veeva: A data partnership for One Medicine
Pharmaphorum
Friday, October 4, 2024 - 9:18am
tags:
Boehringer Ingelheim, Veeva, One Medicine Platform, Clinical Data
Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential $1B Deal
BioSpace
Friday, October 4, 2024 - 9:17am
tags:
Sanofi, Recordati, autoimmune disease, cold agglutinin disease
BMS' Opdivo joins the perioperative lung cancer treatment ring with key FDA approval
Fierce Pharma
Thursday, October 3, 2024 - 10:25pm
tags:
Bristol Myers Squibb, Opdivo, FDA, non-small cell lung cancer
AbbVie cuts 2024 profit forecast citing R&D expenses
Reuters
Thursday, October 3, 2024 - 9:26pm
tags:
AbbVie, R&D
Relay cuts more staff in efforts to save $50M a year
Fierce Biotech
Thursday, October 3, 2024 - 9:25pm
tags:
Relay Therapeutics, precision medicine, layoffs
1 In 4 Physicians Say Prior Authorization Harms Patients. Reform Is Coming
Forbes
Thursday, October 3, 2024 - 8:28pm
tags:
insurance, patients, prior authorizations
Novo Nordisk has mitigation plans to minimize disruption from port strikes
Reuters
Thursday, October 3, 2024 - 11:47am
tags:
Novo Nordisk, logistics, labor strike, Wegovy, Ozempic
Big pharma, biotech relations ‘won't necessarily be symbiotic’ in future AI landscape: S&P
Fierce Biotech
Thursday, October 3, 2024 - 10:57am
tags:
Big Pharma, artificial intelligence, innovation, biotech
FDA grants fast track status for Volastra’s VLS-1488 to treat ovarian cancer
Pharmaceutical Business Review
Thursday, October 3, 2024 - 10:40am
tags:
Volastra Therapeutics, VLS-1488, ovarian cancer, platinum-resistant ovarian cancer
Arcus and AstraZeneca enter trial collaboration for renal cancer treatment
Clinical Trials Arena
Thursday, October 3, 2024 - 10:37am
tags:
Arcus Biosciences, AstraZeneca, renal cancer, casdatifan, renal cell carcinoma
Septerna files for IPO on strength of preclinical data, vision for expanding GPCR landscape
Fierce Biotech
Thursday, October 3, 2024 - 10:32am
tags:
Septerna, IPOs, hypoparathyroidism

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

FDA Approves Exact Sciences' Cologuard Plus Non-Invasive Colorectal Cancer Screening Test
pharmexec
FDA Approves Bristol Myers Squibb’s Opdivo in Combination with Chemotherapy for Resectable Non-Small Cell Lung Cancer
pharmexec
Innovative Models for Improving Access and Visibility for Specialty-Lite and Retail Therapies
Drug Channels
Animating for Your Audience: The Right Visual for Your Dev Stage
pharmexec
BCS Financial Introduces Employer Group Gene Therapy Stop Loss
pharmexec
Combating Diseases with Limited Investment Incentives: Q&A with Dr. Claire Wagner
pharmexec
Hologic Launches Breast Cancer Myth Busting Campaign
pharmexec
Pharma Pulse 10/4/24: Regulatory Challenges With Data Collection, Poor Sleep Quality Linked to Dementia & more
pharmexec
Sun Pharma, Philogen Ink Global Commercialization Deal for Fibromun, an Anti-Cancer Immunotherapy
pharmexec

Latest Jobs

Area Manager-Immunology, Mid-West
Fields, Oregon, 97710
CSL Behring
Hearing Aid Sales Consultant
Groton, Connecticut, 06349
Beltone New England
Business Development Representative
Tampa, Florida, 33646
Complete Care Centers, LLC
Pharmaceutical Sales Customer Engagement- Poughkeepsie, NY
Poughkeepsie, New York,
Otsuka
Pharmaceutical Sales Customer Engagement LTC Key Accounts - Philadelphia, PA
Philadelphia, Pennsylvania,
Otsuka
Pharmaceutical Sales Customer Engagement - Charlotte S, NC
Charlotte, North Carolina,
Otsuka
Pharmaceutical Sales Customer Engagement, CNS - Ann Arbor East, MI (Livonia/ Wayne/ Ypsilanti/ South Lyon)
Livonia, Michigan,
Otsuka
Pharmaceutical Sales Customer Engagement - Morristown, NJ
Morristown, New Jersey,
Otsuka
Pharmaceutical Sales Customer Engagement - Arlington, VA
Arlington, Virginia,
Otsuka
Pharmaceutical Sales Customer Engagement - Jacksonville, FL
Jacksonville, Florida,
Otsuka
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information